Latin America Antibiotic Resistance Market Size & Outlook
The antibiotic resistance market in Latin America is expected to reach a projected revenue of US$ 746.0 million by 2030. A compound annual growth rate of 5.8% is expected of Latin America antibiotic resistance market from 2024 to 2030.
- Pharmaceuticals
- Infectious Disease Treatment
- Antibiotic Resistance Market Outlook
- Infectious Disease Treatment
Revenue, 2023 (US$M)
$501.8
Forecast, 2030 (US$M)
$746.0
CAGR, 2024 - 2030
5.8%
Report Coverage
Latin America
Latin America Antibiotic Resistance Market, 2018-2030 (US$M)
Global Market
Related Markets
Ask Prism AI anything about the antibiotic resistance market
Get a cited answer from GVR research in seconds: segment shares, growth drivers, regulation and forecast assumptions.
Every answer starts with GVR research, and every figure is cited.Explore Prism AI
Latin America antibiotic resistance market highlights
- The Latin America antibiotic resistance market generated a revenue of USD 501.8 million in 2023.
- The market is expected to grow at a CAGR of 5.8% from 2024 to 2030.
- In terms of segment, cuti was the largest revenue generating disease in 2023.
- CDI is the most lucrative disease segment registering the fastest growth during the forecast period.
- Country-wise, Argentina is expected to register the highest CAGR from 2024 to 2030.
Latin America data book summary
| Market revenue in 2023 | USD 501.8 million |
| Market revenue in 2030 | USD 746.0 million |
| Growth rate | 5.8% (CAGR from 2023 to 2030) |
| Largest segment | Cuti |
| Fastest growing segment | CDI |
| Historical data covered | 2018 - 2022 |
| Base year for estimation | 2023 |
| Forecast period covered | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | CUTI, CDI, ABSSSI, HABP, CABP, CIAI, BSI |
| Key market players worldwide | Melinta Therapeutics, Basilea Pharmaceutica Ltd, Theravance Biopharma Inc, Seres Therapeutics Inc, AbbVie Inc, Merck & Co Inc, Hubsan, Wockhardt, Entasis Therapeutics, Tetraphase Pharmaceuticals, Paratek Pharmaceuticals, Axogen Inc |
Other key industry trends
- In terms of revenue, Latin America region accounted for 5.8% of the global antibiotic resistance market in 2023.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 3,572.2 million by 2030.
No credit card required*
Customize the Report
20% free customization
- Include
- Countries, segments, points
- Tailor
- To your product definition
- Extend
- Deeper competitor detail
- Or
- A fully bespoke study
- Turnaround
- 5–10 working days
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Antibiotic Resistance Market Scope
Antibiotic Resistance Market segmentation & scope
Antibiotic Resistance Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| AbbVie Inc | View profile | 50,000 | 1 North Waukegan Road, North Chicago, IL, United States, 60064-6400 | www.abbvieinvestor.com |
| Merck & Co Inc | View profile | 72,000 | 126 East Lincoln Avenue, Rahway, NJ, United States, 07065 | www.merck.com |
| Axogen Inc | View profile | 428 | 13631 Progress Boulevard, Suite 400, Alachua, FL, United States, 32615 | www.axogeninc.com |
| Melinta Therapeutics | View profile | 101-250 | New Haven, Connecticut, United States, North America | melinta.com |
| Basilea Pharmaceutica Ltd | View profile | 147 | Hegenheimermattweg 167b, Allschwil, Switzerland, 4123 | www.basilea.com |
| Theravance Biopharma Inc | View profile | 99 | Ugland House, South Church Street, George Town, PO Box 309, Grand Cayman, Cayman Islands, KY1-1104 | www.theravance.com |
| Seres Therapeutics Inc | View profile | 233 | 101 Cambridgepark Drive, Cambridge, MA, United States, 02140 | www.serestherapeutics.com |
| Hubsan | View profile | 1-10 | Walnut, California, United States, North America | hubsan.com |
| Wockhardt | View profile | 10001+ | Mumbai, Maharashtra, India, Asia | wockhardt.com |
| Entasis Therapeutics | View profile | 51-100 | Waltham, Massachusetts, United States, North America | www.entasistx.com/ |
Latin America Antibiotic Resistance Market Outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Antibiotic Resistance Market Outlook will help companies and investors design strategic landscapes.
Cuti was the largest segment with a revenue share of 25.47% in 2023.
Horizon Databook has segmented the Latin America antibiotic resistance market based on cuti, cdi, absssi, habp, cabp, ciai, bsi covering the revenue growth of each sub-segment from 2018 to 2030.
- Latin America Antibiotic Resistance Market Disease Outlook (Revenue, USD Million , 2018-2030)
- cUTI
- CDI
- ABSSSI
- HABP
- CABP
- cIAI
- BSI
- Latin America Antibiotic Resistance Market Pathogen Outlook (Revenue, USD Million , 2018-2030)
- E.coli
- klebsiella pneumoniae
- P. aeruginosa
- S. aureus
- A. baumannii
- Strep. Pneumoniae
- H. influenzae
- CDI
- Enterococcus fecium
- Latin America Antibiotic Resistance Market Drug Class Outlook (Revenue, USD Million , 2018-2030)
- Oxazolidinones
- Lipoglycopeptides
- Tetracyclines
- Combination therapies
- Cephalosporins
- Other drug classes
- Latin America Antibiotic Resistance Market Mechanism of Action Outlook (Revenue, USD Million , 2018-2030)
- Protein Synthesis Inhibitors
- Cell Wall Synthesis Inhibitors
- RNA Synthesis Inhibitors
- DNA Synthesis Inhibitors
- Other mechanism of actions
- Latin America Antibiotic Resistance Market Distribution Channel Outlook (Revenue, USD Million , 2018-2030)
- Retail Pharmacies
- Hospital Pharmacies
- Online Pharmacies
Reasons to subscribe to Antibiotic Resistance Market Outlook databook
- Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
- Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
- Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
- Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
- Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Antibiotic Resistance Market Outlook databook
- Our clientele includes a mix of Antibiotic Resistance Market Outlook companies, investment firms, advisory firms & academic institutions.
- 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
- Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
- The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Latin America Antibiotic Resistance Market Outlook, including forecasts for subscribers. This continent databook contains high-level insights into Latin America Antibiotic Resistance Market Outlook from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Latin America Antibiotic Resistance Market, 2018-2030 (US$M)
Latin America antibiotic resistance market statistics, by disease, 2018-2030 (US$M)
